Yüklüyor......
The rapamycin-regulated gene expression signature determines prognosis for breast cancer
BACKGROUND: Mammalian target of rapamycin (mTOR) is a serine/threonine kinase involved in multiple intracellular signaling pathways promoting tumor growth. mTOR is aberrantly activated in a significant portion of breast cancers and is a promising target for treatment. Rapamycin and its analogues are...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2761377/ https://ncbi.nlm.nih.gov/pubmed/19778445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-8-75 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|